BAT Announces Repurchase of 74,186 Shares as Part of Ongoing Buyback Program

Nov.28.2024

BAT Announces Repurchase of 74,186 Shares as Part of Ongoing Buyback Program

BAT has repurchased 74,186 shares from Merrill Lynch International, reducing its share count to 2.21 billion, enhancing shareholder value through potential EPS growth.

British American Tobacco PLC (BAT) has repurchased 74,186 ordinary shares at an average price of 2,999.38 pence per share from Merrill Lynch International. This repurchase forms part of the Company's ongoing buyback program, as announced on 28 November.

The transaction, initially announced on 18 March 2024 and authorized by shareholders at the Company's Annual General Meeting on 24 April 2024, was completed on 27 November 2024.

Key details of the transaction are as follows:

Date of purchase: 27 November 2024

Number of shares repurchased: 74,186

Highest price paid per share: 3,010.00 pence

Lowest price paid per share: 2,978.00 pence

Volume weighted average price paid per share: 2,999.38 pence

After the purchase and cancellation, BAT's total number of ordinary shares in issue (excluding treasury shares) will be 2,210,937,032.

This reduction in shares is part of a strategic decision designed to enhance shareholder value by potentially increasing earnings per share.

Additionally, shareholders may need to assess whether they are required to notify any changes to their interest in the company, in accordance with the FCA's Disclosure Guidance and Transparency Rules.

References:

[1] BAT Stock Exchange announcements

#Europe #United Kingdom #Market #Major companies

China Tobacco Regulation Shift：Policy Updates and Market Impact

China Tobacco Regulation Shift：Policy Updates and Market Impact

EVO NXT European Tobacco & NGP Exhibition

EVO NXT European Tobacco & NGP Exhibition

FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs

FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs

FDA Center for Tobacco Products Acting Director Bret Koplow issued a statement on May 7 outlining new steps to accelerate tobacco product premarket application review. The statement said CTP reduced the backlog of applications by approximately 70% in 2025 and that there is no longer a queue for PMTAs pending acceptance review.

May.09 by 2FIRSTS.ai

Disposable Vape Ban Shifts Purchasing Formats as UK Vape Volume Falls 10.3%

Disposable Vape Ban Shifts Purchasing Formats as UK Vape Volume Falls 10.3%

Data from convenience insight agency Talysis shows that the value of tobacco, vapes and smoking alternatives in the independent convenience sector fell by 4.4% in the first quarter of 2026, while volume fell by 7.8%. The vaping subcategory declined by 3.9% in value and 10.3% in volume over the same period. Talysis said the impact of the disposable vape ban continues to pressure turnover and footfall.

May.08 by 2FIRSTS.ai

Fifth Circuit Hears Challenge to FDA’s Standard for Reviewing Flavored Vape Applications

Fifth Circuit Hears Challenge to FDA’s Standard for Reviewing Flavored Vape Applications

A three-judge panel of the U.S. Court of Appeals for the Fifth Circuit heard oral arguments on Tuesday in a case brought by seven small vape-liquid companies challenging the Food and Drug Administration’s denial of marketing authorization for their flavored electronic nicotine products.

Apr.30 by 2FIRSTS.ai

Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year

Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year

FDA Center for Tobacco Products Acting Director Bret Koplow said at the American Tobacco and Nicotine Forum that the agency has reduced its premarket tobacco application backlog by about 70% over the past year and eliminated the acceptance queue. He said FDA has reviewed about 27 million applications, but only a small number have been authorized, mainly because most submissions lacked the scientific data needed to demonstrate public health benefits.

Apr.23 by 2FIRSTS.ai

OLAF and Customs Authorities From 30 Countries Seize More Than 94 Million Illicit Vape and Heated Tobacco Items

OLAF and Customs Authorities From 30 Countries Seize More Than 94 Million Illicit Vape and Heated Tobacco Items

The European Anti-Fraud Office said on April 17 that its “JCO VAPE” operation, carried out together with customs authorities from 30 countries, successfully targeted the illicit trade in e-cigarettes and heated tobacco products. The operation, conducted from November 14 to December 15, 2025, resulted in seizures of more than 94 million items and more than 2,500 kg/l of tobacco products, e-cigarettes, devices, and related goods.

Apr.20 by 2FIRSTS.ai

KT&G Moves Ahead With Oral Nicotine Product Development and Pilot Line Preparation

KT&G Moves Ahead With Oral Nicotine Product Development and Pilot Line Preparation

According to a Korean media report, KT&G is developing a smokeless nicotine product that delivers nicotine through oral absorption and is preparing a pilot production line for research and development.

Apr.08 by 2FIRSTS.ai

Related Topics

Related Read

FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs

FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs

Disposable Vape Ban Shifts Purchasing Formats as UK Vape Volume Falls 10.3%

Disposable Vape Ban Shifts Purchasing Formats as UK Vape Volume Falls 10.3%

Fifth Circuit Hears Challenge to FDA’s Standard for Reviewing Flavored Vape Applications

Fifth Circuit Hears Challenge to FDA’s Standard for Reviewing Flavored Vape Applications

Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year

Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year

OLAF and Customs Authorities From 30 Countries Seize More Than 94 Million Illicit Vape and Heated Tobacco Items

OLAF and Customs Authorities From 30 Countries Seize More Than 94 Million Illicit Vape and Heated Tobacco Items

KT&G Moves Ahead With Oral Nicotine Product Development and Pilot Line Preparation

KT&G Moves Ahead With Oral Nicotine Product Development and Pilot Line Preparation